Polaryx Therapeutics, Inc. PLYX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Polaryx Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Polaryx Therapeutics, Inc. 's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Polaryx Therapeutics, Inc. 's total equity?
- Polaryx Therapeutics, Inc. (PLYX) reported total equity of $2.49M in Q1 2026.
- How has Polaryx Therapeutics, Inc. 's total equity changed year-over-year?
- Polaryx Therapeutics, Inc. 's total equity decreased by 41.5% year-over-year, from $4.25M to $2.49M.
- What is the long-term trend for Polaryx Therapeutics, Inc. 's total equity?
- Over 2 years (2023 to 2025), Polaryx Therapeutics, Inc. 's total equity has grown at a 89.1% compound annual growth rate (CAGR), from $1.28M to $4.57M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.